BackCellev8 Nutrition Overview

Cellev8 Nutrition EBIT

Track Cellev8 Nutrition's EBIT ($-2.9M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow

Quarterly EBIT

-$1.59M
↓ 445.25% YoY

As of Aug 31, 2026

Annual EBIT (TTM)

-$2.86M
↓ 49.64% YoY

Trailing 12 months ending Aug 31, 2026

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Cellev8 Nutrition (CELV) FAQ

The latest EBIT for CELV is $-2.9M as of August 2026. That compares with $-1.9M in the prior-year period — down 49.6% year over year. That is below the sector sector average of $2.4T. Investors often review this figure alongside Cellev8 Nutrition's historical trend and sector peers before judging valuation or financial health.

Over the past year, CELV's EBIT moved from $-1.9M to $-2.9M — a 49.6% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Cellev8 Nutrition's operating scale or balance-sheet position.

Against its sector companies, CELV currently prints $-2.9M for EBIT, while the sector average sits near $2.4T. That is roughly 100.0% below the sector mean. Large gaps often invite a closer look at Cellev8 Nutrition's growth, margins, and balance sheet.

A EBIT figure of $-2.9M for CELV is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The sector average is about $2.4T. Explore the charts below for those layers of context.

After noting CELV's EBIT ($-2.9M), review year-over-year change from $-1.9M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.